BioSpace News Archive

Policy

GeneLink, Inc. Reports Denial of Appeal

April 5, 2011
·
1 min read
Drug Development

Neurocrine Biosciences, Inc. Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor

April 5, 2011
·
5 min read
GeNO LLC Receives Additional Patent for Inhaled NITROSYL(TM) Nitric Oxide Product

April 5, 2011
·
2 min read
FDA to Address Industry Questions About Biosimilar Regulations at the Pharma IQ’s Immunogenicity Event

April 5, 2011
·
2 min read
Drug Development

Tolerx, Inc. Presents Preclinical Data on Novel Anti-GITR Cancer Immunotherapeutic Demonstrating Enhanced Anti-Tumor Responses

April 5, 2011
·
3 min read
Business

Par Pharmaceutical Companies, Inc. to Report First Quarter 2011 Results on May 5, 2011

April 5, 2011
·
1 min read
Genetown

Generex Biotechnology Corporation Launches New Corporate Website

April 5, 2011
·
4 min read
Deals

Royalty Pharma Acquires Lexiscan(R) and Cubicin(R) Royalties for $487 Million

April 5, 2011
·
2 min read
AEterna Zentaris Announces Results on AEZS-131, a Highly Selective Erk 1/2 Inhibitor Anticancer Compound at American Association for Cancer Research Annual Meeting

April 5, 2011
·
3 min read
Drug Development

Argos Therapeutics, Inc. to Present Corporate Overview and Next Steps in Clinical Development of Arcelis(TM) Immunotherapy at Needham & Company 10th Annual Healthcare Conference and Leerink Swann and Company Cancer Roundtable Conference

April 5, 2011
·
2 min read